{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T09:34:01Z","timestamp":1771666441849,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.ajo.2011.04.011","type":"journal-article","created":{"date-parts":[[2011,7,15]],"date-time":"2011-07-15T03:47:26Z","timestamp":1310701646000},"page":"799-806.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Diagnostic Evaluation of Type 2 (Classic) Choroidal Neovascularization: Optical Coherence Tomography, Indocyanine Green Angiography, and Fluorescein Angiography"],"prefix":"10.1016","volume":"152","author":[{"given":"Florian","family":"Sulzbacher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Munk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabor","family":"Deak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Sacu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Schmidt-Erfurth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ajo.2011.04.011_bib1","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1001\/archopht.116.5.653","article-title":"Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study","volume":"116","author":"Klaver","year":"1998","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2011.04.011_bib2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0161-6420(96)30684-2","article-title":"Visual acuity and the causes of visual loss in Australia","volume":"103","author":"Attebo","year":"1996","journal-title":"Opthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2011.04.011_bib3","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s003470050276","article-title":"Choroidale Neovaskularisationen bei AMD; Korrelation histologischer und fluoreszenzangiographischer Befunde [in German]","volume":"95","author":"Hoops","year":"1998","journal-title":"Ophthalmologe"},{"issue":"1","key":"10.1016\/j.ajo.2011.04.011_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0002-9394(98)00145-7","article-title":"Clinicopathologic correlations of surgically excised type 1 and type 2 submacular choroidal neovascular membranes","volume":"126","author":"Grossniklaus","year":"1998","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2011.04.011_bib5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0161-6420(95)31017-2","article-title":"The digital indocyanine green videoangiography characteristics of well-defined choroidal neovascularization","volume":"102","author":"Awad","year":"1995","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2011.04.011_bib6","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1167\/iovs.05-0370","article-title":"Three-dimensional ultrahigh-resolution optical coherence tomography of macular diseases","volume":"46","author":"Schmidt-Erfurth","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.ajo.2011.04.011_bib7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ophtha.2007.03.008","article-title":"The natural history and prognosis of neovascular age-related macular degeneration","volume":"115","author":"Wong","year":"2008","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ajo.2011.04.011_bib8","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.ophtha.2009.03.055","article-title":"Natural history of predominantly classic, minimally classic, and occult subgroups in exudative age-related macular degeneration","volume":"116","author":"Shah","year":"2009","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2011.04.011_bib9","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/archopht.1991.01080090066027","article-title":"Subfoveal neovascular lesions in age related macular degeneration","volume":"109","year":"1991","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2011.04.011_bib10","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0021-5155(98)00010-0","article-title":"Indocyanine green angiography in classic choroidal neovascularization","volume":"42","author":"Gelisken","year":"1998","journal-title":"Jpn J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2011.04.011_bib11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/bjo.83.4.429","article-title":"Indocyanine green angiographic features prognostic of visual outcome in the natural course of patients with age related macular degeneration","volume":"83","author":"Obana","year":"2009","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2011.04.011_bib12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/bjo.2003.024893","article-title":"Indocyanine green localisation in surgically excised choroidal neovascular membrane in age-related macular degeneration","volume":"88","author":"Chang","year":"2004","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2011.04.011_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00417-009-1193-4","article-title":"Relationship between angiographic and optical coherence tomographic (OCT) parameters for quantifying choroidal neovascular lesions","volume":"248","author":"Sadda","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2011.04.011_bib14","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1038\/eye.2008.241","article-title":"Ranibizumab: the clinician's guide to commencing, continuing and discontinuing treatment","volume":"23","author":"Amoaku","year":"2009","journal-title":"Eye"},{"issue":"4","key":"10.1016\/j.ajo.2011.04.011_bib15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/bjo.83.4.429","article-title":"Indocyanine green angiographic features prognostic of visual outcome in the natural course of patients with age related macular degeneration","volume":"83","author":"Obana","year":"1999","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2011.04.011_bib16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0002-9394(03)00223-X","article-title":"Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1","volume":"136","author":"Blinder","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2011.04.011_bib17","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ophtha.2006.10.045","article-title":"Subgroup analyses of the MARINA study of ranibizumab in neovascular age-related macular degeneration","volume":"114","author":"Beyer","year":"2007","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2011.04.011_bib18","first-page":"389","article-title":"One-year results of intravitreal ranibizumab for neovascular age-related macular degeneration and clinical responses of various subgroups","volume":"53","author":"Kang","year":"2009","journal-title":"Jpn J Ophthlmol"},{"issue":"1","key":"10.1016\/j.ajo.2011.04.011_bib19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ophtha.2008.10.018","article-title":"Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study","volume":"116","author":"Brown","year":"2009","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2011.04.011_bib20","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ajo.2007.08.012","article-title":"Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results","volume":"144","author":"Kaiser","year":"2007","journal-title":"Am J Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939411003229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939411003229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:03:00Z","timestamp":1757595780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939411003229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0002939411003229"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2011.04.011","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic Evaluation of Type 2 (Classic) Choroidal Neovascularization: Optical Coherence Tomography, Indocyanine Green Angiography, and Fluorescein Angiography","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2011.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}